IS6127A - Ný kristölluð form af makrólíð sýklalyfi - Google Patents

Ný kristölluð form af makrólíð sýklalyfi

Info

Publication number
IS6127A
IS6127A IS6127A IS6127A IS6127A IS 6127 A IS6127 A IS 6127A IS 6127 A IS6127 A IS 6127A IS 6127 A IS6127 A IS 6127A IS 6127 A IS6127 A IS 6127A
Authority
IS
Iceland
Prior art keywords
crystalline form
new crystalline
macrolide antibiotic
macrolide
antibiotic
Prior art date
Application number
IS6127A
Other languages
English (en)
Inventor
John Rafka Robert
John Meldrum Allen Douglas
Brendan Ragan Colman
James Morton Barry
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS6127A publication Critical patent/IS6127A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IS6127A 1999-05-18 2001-10-26 Ný kristölluð form af makrólíð sýklalyfi IS6127A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18
PCT/IB2000/000463 WO2000069874A1 (en) 1999-05-18 2000-04-14 Novel crystalline forms of a macrolide antibiotic

Publications (1)

Publication Number Publication Date
IS6127A true IS6127A (is) 2001-10-26

Family

ID=22464300

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6127A IS6127A (is) 1999-05-18 2001-10-26 Ný kristölluð form af makrólíð sýklalyfi

Country Status (43)

Country Link
US (1) US6583274B1 (is)
EP (1) EP1189912B1 (is)
JP (1) JP3897983B2 (is)
KR (1) KR100474229B1 (is)
CN (1) CN1203084C (is)
AP (1) AP2001002325A0 (is)
AR (1) AR020030A1 (is)
AT (1) ATE392427T1 (is)
AU (1) AU772283B2 (is)
BG (1) BG106150A (is)
BR (1) BR0011300A (is)
CA (1) CA2372206C (is)
CZ (1) CZ20014120A3 (is)
DE (1) DE60038610T2 (is)
DK (1) DK1189912T3 (is)
DZ (1) DZ3043A1 (is)
EA (1) EA003417B1 (is)
ES (1) ES2302689T3 (is)
GT (1) GT200000072A (is)
HK (1) HK1045521B (is)
HN (1) HN2000000056A (is)
HR (1) HRP20010849A2 (is)
HU (1) HUP0201341A3 (is)
IL (2) IL145946A0 (is)
IS (1) IS6127A (is)
MA (1) MA26735A1 (is)
MX (1) MXPA01011914A (is)
MY (1) MY133397A (is)
NO (1) NO320195B1 (is)
NZ (1) NZ514765A (is)
OA (1) OA11876A (is)
PA (1) PA8495001A1 (is)
PE (1) PE20010151A1 (is)
PL (1) PL353316A1 (is)
PT (1) PT1189912E (is)
SK (1) SK16472001A3 (is)
TN (1) TNSN00103A1 (is)
TW (1) TWI225066B (is)
UA (1) UA67842C2 (is)
UY (1) UY26144A1 (is)
WO (1) WO2000069874A1 (is)
YU (1) YU76601A (is)
ZA (1) ZA200109420B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
PT1250343E (pt) 2000-01-27 2003-11-28 Pfizer Prod Inc Composicoes de antibioticos de azalida
CA2445306C (en) * 2001-04-27 2008-02-12 Pfizer Products Inc. Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
AU2003271408B2 (en) * 2002-12-31 2008-07-17 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
ES2412059T3 (es) * 2009-01-30 2013-07-10 Glaxo Group Limited Macrólido antiinflamatorio
EP2402355A1 (en) * 2010-07-01 2012-01-04 Novartis AG Crystalline anhydrous forms II and III of Tulathromycin
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN109942652B (zh) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 一种莱柯霉素晶型ⅰ及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
DE60038610T2 (de) 2009-06-25
DE60038610D1 (de) 2008-05-29
HK1045521A1 (en) 2002-11-29
AU772283B2 (en) 2004-04-22
MA26735A1 (fr) 2004-12-20
CN1203084C (zh) 2005-05-25
TWI225066B (en) 2004-12-11
PE20010151A1 (es) 2001-02-08
UA67842C2 (uk) 2004-07-15
ZA200109420B (en) 2002-11-15
BG106150A (bg) 2002-05-31
CN1351607A (zh) 2002-05-29
PT1189912E (pt) 2008-05-16
NO20015598L (no) 2002-01-08
CZ20014120A3 (cs) 2003-01-15
NO320195B1 (no) 2005-11-14
TNSN00103A1 (fr) 2005-11-10
AP2001002325A0 (en) 2001-12-31
KR100474229B1 (ko) 2005-03-08
EP1189912A1 (en) 2002-03-27
SK16472001A3 (sk) 2003-02-04
YU76601A (sh) 2004-09-03
JP3897983B2 (ja) 2007-03-28
CA2372206A1 (en) 2000-11-23
PL353316A1 (en) 2003-11-17
AR020030A1 (es) 2002-03-27
HUP0201341A3 (en) 2003-03-28
JP2002544283A (ja) 2002-12-24
US6583274B1 (en) 2003-06-24
NZ514765A (en) 2004-05-28
EA200100984A1 (ru) 2002-06-27
MXPA01011914A (es) 2002-05-06
DZ3043A1 (fr) 2004-03-27
WO2000069874A1 (en) 2000-11-23
GT200000072A (es) 2001-11-08
BR0011300A (pt) 2002-02-26
ATE392427T1 (de) 2008-05-15
CA2372206C (en) 2006-01-10
EA003417B1 (ru) 2003-04-24
KR20020007415A (ko) 2002-01-26
AU3572900A (en) 2000-12-05
EP1189912B1 (en) 2008-04-16
ES2302689T3 (es) 2008-08-01
OA11876A (en) 2006-03-27
HUP0201341A2 (en) 2002-08-28
DK1189912T3 (da) 2008-06-30
PA8495001A1 (es) 2002-02-21
NO20015598D0 (no) 2001-11-16
HRP20010849A2 (en) 2003-04-30
IL145946A (en) 2007-06-17
HN2000000056A (es) 2001-02-02
HK1045521B (zh) 2005-12-09
MY133397A (en) 2007-11-30
UY26144A1 (es) 2000-12-29
IL145946A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
ATE345350T1 (de) Makrolidantibiotika
DK2198858T3 (da) Præparat med opretholdt frigivelse af en makrolidforbindelse såsom tacrolimus
EE200300575A (et) Asitromütsiini kristalsed vormid
DE60003586D1 (de) Antibiotische azalid-zusammensetzungen
DK1183345T3 (da) Styret evolution af mikroorganismer
NO20021747D0 (no) Blandinger av erytromycinderivater med forlenget frigivelse
ID30233A (id) Antibiotika ketolida
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
EE200100245A (et) Uued makroliidsed antibiootikumid
DK1149090T3 (da) Ny krystallinsk form af kaliumsalt af (S)-omeprazol
NO20020030D0 (no) Krystallinske 1-metylcarbapenemforbindelser
NO20014362D0 (no) Erytromycinderivater
IS6127A (is) Ný kristölluð form af makrólíð sýklalyfi
DK1280803T3 (da) Krystallinsk form II af cabergolin
NO20006255L (no) Krystallinsk efavirenz
IS6215A (is) Að mestu leyti kristallað form af melagatrani
IS5821A (is) Kristalluð form af ósanetant
ID26418A (id) METODA KRISTALISASI ANTIBIOTIK β-LAKTAM
NO20013857L (no) Krystallinsk form av Eplerenon
NO20004583D0 (no) Krystallinsk form av paroxetine
SE9904417D0 (sv) Crystalline form
SE0001187D0 (sv) Crystalline form
SE0001422D0 (sv) Crystalline form
DK1191025T3 (da) Krystaller af lansoprazol